SPRINT-TB Projects in the TB Drug Pipeline Report

In August 2016, selected SPINT-TB drug development projects were added to the TB Drug Pipeline report maintained by Working Group on New TB Drugs. Working Group on New Drugs (WGND) is one of the Stop TB Partnership's seven Working Groups - a network of experts committed to accelerating the development of effective and affordable new therapies for TB. The WGND acts as a forum to facilitate global collaborations and joint projects for the development of new TB drugs and promotes coordination of all stakeholders in this process.

View WGND TB drug pipeline at http://www.newtbdrugs.org .